Meijer Maura, Oliveri Federico, van Oort Martijn J H, Bingen Brian O, van der Kley Frank, Jukema J Wouter, Al Amri Ibtihal, Montero-Cabezas J M
Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.
Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.
Cardiovasc Revasc Med. 2025 Jan;70:85-91. doi: 10.1016/j.carrev.2024.07.004. Epub 2024 Jul 22.
Coronary artery bypass grafting (CABG) is a cornerstone treatment for coronary artery disease, with the use of saphenous vein grafts (SVGs) being prevalent. However, SVGs are susceptible to high failure rates due to graft inflammation, intimal hyperplasia, and atherosclerosis, leading to a substantial number of patients requiring revascularization. Percutaneous coronary intervention (PCI) of SVGs poses unique challenges, including increased risk of distal embolization and perforation due to the grafts' structure and atherosclerotic nature. The role of intravascular lithotripsy (IVL) in calcific SVG lesions has not been elucidated.
We retrospectively analyzed four cases of patients treated with IVL for SVG stenosis at Leiden University Medical Centre between May 2019 and December 2023. Quantitative coronary analysis and intravascular ultrasound were utilized to assess procedural success and mid- to long-term clinical outcomes were reported as well.
In all 4 cases, IVL was performed in stent (2 due to calcific in-stent neoatherosclerosis; 2 bail-out due to extrinsic stent calcification). No major adverse cardiovascular events (MACE) were reported during mid- to long-term follow-up. The procedure demonstrated effective calcium cracking, leading to optimal stent expansion and minimal residual stenosis with a low risk of procedural complications.
IVL represents a promising approach for managing calcified peri-stent SVG lesions, showing potential for safe and effective revascularization with minimal complications. These findings suggest that IVL could be incorporated into the treatment paradigm for calcified peri-stent SVG stenosis, warranting further investigation in larger, prospective studies to validate its efficacy and safety.
冠状动脉旁路移植术(CABG)是冠心病的基石性治疗方法,大隐静脉移植物(SVG)的使用很普遍。然而,由于移植物炎症、内膜增生和动脉粥样硬化,SVG易出现高失败率,导致大量患者需要进行血运重建。SVG的经皮冠状动脉介入治疗(PCI)带来了独特的挑战,包括由于移植物的结构和动脉粥样硬化性质导致远端栓塞和穿孔的风险增加。血管内碎石术(IVL)在钙化SVG病变中的作用尚未阐明。
我们回顾性分析了2019年5月至2023年12月在莱顿大学医学中心接受IVL治疗SVG狭窄的4例患者。采用定量冠状动脉分析和血管内超声评估手术成功率,并报告中长期临床结果。
在所有4例病例中,IVL均在支架内进行(2例由于支架内钙化性新动脉粥样硬化;2例因外部支架钙化进行补救)。中长期随访期间未报告重大不良心血管事件(MACE)。该手术显示出有效的钙裂解,导致支架最佳扩张和最小残余狭窄,手术并发症风险低。
IVL是治疗钙化性支架周围SVG病变的一种有前景的方法,显示出安全有效血运重建且并发症最少的潜力。这些发现表明,IVL可纳入钙化性支架周围SVG狭窄的治疗模式,需要在更大规模的前瞻性研究中进一步研究以验证其疗效和安全性。